[EQ] Trade, TRIPS, and pharmaceuticals

Trade, TRIPS, and pharmaceuticals

 

Prof Richard D Smith, Prof Carlos Correa, Cecilia Oh

Health Policy Unit, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK

(Prof R D Smith PhD); Centre for Interdisciplinary Studies on Industrial Property and Economics Law, University of Buenos Aires, Buenos Aires, Argentina (Prof C Correa PhD);

and UNDP Regional Centre, Colombo, Sri Lanka (C Oh PhD

Lancet, Volume 373, Issue 9664, Pages 684 - 691, 21 February 2009

 

 

Summary: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(08)61779-1/abstract [Subscription required]

 

“…..The World Trade Organization's Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) set global minimum standards for the protection of intellectual property, substantially increasing and expanding intellectual-property rights, and generated clear gains for the pharmaceutical industry and the developed world.

 

The question of whether TRIPS generates gains for developing countries, in the form of increased exports, is addressed in this paper through consideration of the importance of pharmaceuticals in health-care trade, outlining the essential requirements, implications, and issues related to TRIPS, and TRIPS-plus, in which increased restrictions are imposed as part of bilateral free-trade agreements. TRIPS has not generated substantial gains for developing countries, but has further increased pharmaceutical trade in developed countries.

 

The unequal trade between developed and developing countries (ie, exporting and importing high-value patented drugs, respectively) raises the issue of access to medicines, which is exacerbated by TRIPS-plus provisions, although many countries have not even enacted provision for TRIPS flexibilities. Therefore this paper focuses on options that are available to the health community for negotiation to their advantage under TRIPS, and within the presence of TRIPS-plus…..”

 

 

*      *      *     *

This message from the Pan American Health Organization, PAHO/WHO, is part of an effort to disseminate
information Related to: Equity; Health inequality; Socioeconomic inequality in health; Socioeconomic
health differentials; Gender; Violence; Poverty; Health Economics; Health Legislation; Ethnicity; Ethics;
Information Technology - Virtual libraries; Research & Science issues.  [DD/ KMC Area]

“Materials provided in this electronic list are provided "as is". Unless expressly stated otherwise, the findings
and interpretations included in the Materials are those of the authors and not necessarily of The Pan American
Health Organization PAHO/WHO or its country members”.
---------------------------------------------------------------------------------------------------

PAHO/WHO Website: http://66.101.212.219/equity/

Archives - Join/remove: http://listserv.paho.org/Archives/equidad.html

 

    IMPORTANT: This transmission is for use by the intended recipient and it may contain privileged, proprietary or confidential information. If you are not the intended recipient or a person responsible for delivering this transmission to the intended recipient, you may not disclose, copy or distribute this transmission or take any action in reliance on it. If you received this transmission in error, please notify us immediately by email to infosec@paho.org, and please dispose of and delete this transmission. Thank you.